- Home
- FNLC vs STXS Comparison
FNLC vs STXS Comparison
Compare FNLC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- STXS
- Stock Information
- Founded
- FNLC 1864
- STXS 1990
- Country
- FNLC United States
- STXS United States
- Employees
- FNLC N/A
- STXS 139
- Industry
- FNLC Major Banks
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FNLC Finance
- STXS Health Care
- Exchange
- FNLC Nasdaq
- STXS Nasdaq
- Market Cap
- FNLC 303.4M
- STXS 254.1M
- IPO Year
- FNLC 1999
- STXS 2004
- Fundamental
- Price
- FNLC $26.79
- STXS $2.79
- Analyst Decision
- FNLC
- STXS
- Analyst Count
- FNLC 0
- STXS 0
- Target Price
- FNLC N/A
- STXS N/A
- AVG Volume (30 Days)
- FNLC 15.7K
- STXS 343.7K
- Earning Date
- FNLC 10-22-2025
- STXS 11-10-2025
- Dividend Yield
- FNLC 5.52%
- STXS N/A
- EPS Growth
- FNLC 13.09
- STXS N/A
- EPS
- FNLC 2.68
- STXS N/A
- Revenue
- FNLC $85,448,000.00
- STXS $31,806,000.00
- Revenue This Year
- FNLC N/A
- STXS $30.92
- Revenue Next Year
- FNLC N/A
- STXS $43.27
- P/E Ratio
- FNLC $9.86
- STXS N/A
- Revenue Growth
- FNLC 10.86
- STXS 33.94
- 52 Week Low
- FNLC $22.11
- STXS $1.54
- 52 Week High
- FNLC $31.05
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- FNLC 51.58
- STXS 52.07
- Support Level
- FNLC $26.32
- STXS $2.73
- Resistance Level
- FNLC $27.32
- STXS $2.94
- Average True Range (ATR)
- FNLC 0.44
- STXS 0.09
- MACD
- FNLC -0.10
- STXS -0.03
- Stochastic Oscillator
- FNLC 36.72
- STXS 38.89
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.